Expert Opinion on Investigational Drugs

Published by: Taylor & Francis Group  

People

  1. Adusumilli
    Adusumilli
  2. Amador Molina
    Amador Molina
  3. Chiosis
    Chiosis
  4. Dunphy
    Dunphy
  5. Eastham
    Eastham
  6. Hassoun
    Hassoun
  7. Hou
    Hou
  8. Janjigian
    Janjigian
  9. Jhaveri
    Jhaveri
  10. Lichtman
    Lichtman

Groups

  1. Department of Medicine (6)
  2. Hematologic Malignancies, Division of (4)
  3. Solid Tumor Oncology Division (4)
  4. Center for Hematologic Malignancies (3)
  5. Molecular Pharmacology and Chemistry Program Faculty (3)
  6. Sloan Kettering Institute Faculty (3)
  7. Surgery (3)
  8. GSK Faculty (2)
  9. Genitourinary Oncology Service (2)
  10. Hematologic Malignancies Research (2)
Search Within
Formats
  1. Journal Article (12)
  2. Review (2)
Groups
  1. Department of Medicine (6)
  2. Hematologic Malignancies, Division of (4)
  3. Solid Tumor Oncology Division (4)
  4. Center for Hematologic Malignancies (3)
  5. Molecular Pharmacology and Chemistry Program Faculty (3)
  6. Sloan Kettering Institute Faculty (3)

More Groups

People
  1. Paul Marks (3)
  2. Adriana Dionigi Corben (1)
  3. Alfredo Amador Molina (1)
  4. David Scheinberg (1)
  5. Erica Gomes-Dagama (1)
  6. Gabriela Chiosis (1)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2017 (1)
  4. 2015 (1)
  5. 2014 (1)
  6. 2010 (1)

More Years

Publishers
  1. Taylor & Francis Group (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation immunotherapy for solid tumors: Combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1
    Review

    Quach, H. T.; Hou, Z.; Bellis, R. Y.; Saini, J. K.; Amador-Molina, A.; Adusumilli, P. S.; Xiong, Y.
    Expert Opinion on Investigational Drugs (2022)

    Fulltext@MSK | Save
  • Melflufen for relapsed and refractory multiple myeloma
    Review

    Oriol, A.; Larocca, A.; Leleu, X.; Hajek, R.; Hassoun, H.; Rodríguez-Otero, P.; Paner, A.; Schjesvold, F. H.; Gullbo, J.; Richardson, P. G.
    Expert Opinion on Investigational Drugs (2020)

    Fulltext@MSK | Save
  • Considerations for clinical trial design in older adults with cancer
    Journal Article

    Soto-Perez-De-Celis, E.; Lichtman, S. M.
    Expert Opinion on Investigational Drugs (2017)

    Fulltext@MSK | Save
  • Buparlisib, an oral pan-PI3K inhibitor for the treatment of breast cancer
    Journal Article

    Geuna, E.; Milani, A.; Martinello, R.; Aversa, C.; Valabrega, G.; Scaltriti, M.; Montemurro, F.
    Expert Opinion on Investigational Drugs (2015)

    Fulltext@MSK | Save
  • Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions
    Journal Article

    Jhaveri, K.; Ochiana, S. O.; Dunphy, M. P. S.; Gerecitano, J. F.; Corben, A. D.; Peter, R. I.; Janjigian, Y. Y.; Gomes DaGama, E. M.; Koren, J. 3rd; Modi, S.; more...
    Expert Opinion on Investigational Drugs (2014)

    Fulltext@MSK | Save
  • The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
    Journal Article

    Marks, P. A.
    Expert Opinion on Investigational Drugs (2010)

    Fulltext@MSK | Save
  • Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy
    Journal Article

    Kelly, K. J.; Wong, J.; Fong, Y.
    Expert Opinion on Investigational Drugs (2008)

    Fulltext@MSK | Save
  • Sunitinib malate for the treatment of solid tumours: A review of current clinical data
    Journal Article

    Motzer, R. J.; Hoosen, S.; Bello, C. L.; Christensen, J. G.
    Expert Opinion on Investigational Drugs (2006)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: Discovery and development as anticancer agents
    Journal Article

    Marks, P. A.; Dokmanovic, M.
    Expert Opinion on Investigational Drugs (2005)

    Fulltext@MSK | Save
  • Cancer immunotherapeutics meeting
    Journal Article

    Slovin, S. F.
    Expert Opinion on Investigational Drugs (2004)

    Fulltext@MSK | Save

    • Expert Opinion on Investigational Drugs – authorized name for:

    Name ISSN / ISBN Publisher
    Expert Opinion on Investigational Drugs 13543784 Ashley Publications Ltd
    Expert Opinion on Investigational Drugs 1354-3784 Unknown
    Expert Opinion on Investigational Drugs 1354-3784 Taylor & Francis Group
    Expert Opinion on Investigational Drugs 13543784 Ashley Publications Ltd
    Expert Opinion on Investigational Drugs 13543784 Informa Healthcare
    Expert Opinion on Investigational Drugs 13543784 Informa Healthcare
    Expert Opinion on Investigational Drugs 1354-3784 Informa Healthcare
    Expert Opinion on Investigational Drugs 1354-3784 Ashley Publications Ltd
    Expert Opinion on Investigational Drugs 1354-3784 Informa Healthcare
    Expert Opinion on Investigational Drugs 1354-3784 Ashley Publications Ltd
    Expert Opinion on Investigational Drugs 13543784 Unknown
    Expert Opinion on Investigational Drugs 1354-3784 Informa Healthcare
    Expert Opinion on Investigational Drugs 1354-3784 Taylor & Francis Group
    Expert Opinion on Investigational Drugs 1354-3784 Taylor & Francis Group
    Expert Opinion on Investigational Drugs 17447658 Informa Healthcare
    Expert Opinion on Investigational Drugs 13543784 Informa Uk Limited, Trading As Taylor & Francis Group
    Expert Opinion on Investigational Drugs 13543784 Informa Healthcare
    Expert Opinion on Investigational Drugs 1354-3784 Informa Healthcare